Provasculon Company

Provasculon develops novel forms of stromal cell-derived factor-1 for the treatment of cardiovascular diseases and diabetic ulcers.

Investors

Industry: General Healthcare
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2007-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Total Funding: $7 250 000
Last Funding Date: 2011-11-09
Last Funding Type: Debt Financing

Visit Website
Register and Claim Ownership